Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contraceptive methods in women with sickle cell disease
RBR-62qgf6Completed
- Sponsor
- IMIP
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of avatrombopag, ethinyl estradiol, medroxyprogesterone acetate and desogestrel in contraception (5 arms), sponsored by IMIP. Started Jan 2018; status: completed.
02
Drugs
avatrombopagethinyl estradiolmedroxyprogesterone acetatedesogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on RBR-62qgf6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-62qgf6.